An acknowledged exception to this notion is the PCa neuroendocrine differentiation, in which FOLH1 expression has been shown to inversely correlate with neuron-specific enolase and somatostatin-receptor 2 in the pre-clinical analysis performed by Bakht et al. [49]. The gene discussed is ENO2; the disease is posterior cortical atrophy.